← Back to Search

Functional Fitness for Obesity with Limited Mobility (COBRE Pilot Trial)

N/A

Recruiting

Research Sponsored by University of Kansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18-64 years of age

Have a permanent disability that affects mobility (1 year +);

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline sleep at 6 months (post-intervention)

Awards & highlights

No Placebo-Only Group

Summary

This trial will evaluate the feasibility and potential effectiveness of an exercise intervention to improve body weight and obesity-related health conditions in adults with mobility-related disabilities.

Who is the study for?

This trial is for adults aged 18-64 with mobility-related disabilities who are overweight or obese (BMI of 24-45). Participants must not have previously joined a functional fitness program and need a doctor's approval to exercise. They should be able to make decisions for themselves.

What is being tested?

The study tests if high-intensity functional training (HIFT) can help manage weight and improve health in adults with mobility disabilities. It involves exercising three times a week for six months, aiming to see changes in body composition and metabolic health.

What are the potential side effects?

While the description doesn't list specific side effects, typical risks of high-intensity exercise may include muscle soreness, fatigue, joint stress, or injury. The intensity will be tailored to individuals' abilities considering their disabilities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 64 years old.

Select...

I have a disability that has affected my ability to move for over a year.

Select...

I am my own legal guardian.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline blood pressure (diastolic and systolic) at 6 months (post-intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline blood pressure (diastolic and systolic) at 6 months (post-intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline blood pressure (diastolic and systolic) at 6 months (post-intervention) for reporting.